{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:09:16Z","timestamp":1759018156065,"version":"3.44.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.jinf.2012.07.002","type":"journal-article","created":{"date-parts":[[2012,7,11]],"date-time":"2012-07-11T06:33:52Z","timestamp":1341988432000},"page":"467-470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Body fat changes and mitochondrial alterations during HBV treatment: A warning for long term administration"],"prefix":"10.1016","volume":"65","author":[{"given":"Giordano","family":"Madeddu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Soddu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franca","family":"Mannu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto A.","family":"Muredda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Garrucciu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Bandiera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Zaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Stella","family":"Mura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Babudieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2012.07.002_bib1","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B","author":"European Association For The Study Of The Liver","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jinf.2012.07.002_bib2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jinf.2010.03.002","article-title":"Hepatitis B genotypes and response to adefovir treatment in patients with HBV chronic infection","volume":"60","author":"Scotto","year":"2010","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2012.07.002_bib3","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/00002030-199909100-00009","article-title":"A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy","volume":"13","author":"Saint-Marc","year":"1999","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.jinf.2012.07.002_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jinf.2008.03.007","article-title":"CISAI study group. Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice: results from the SIMONE study","volume":"57","author":"De Socio","year":"2008","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2012.07.002_bib5","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","article-title":"Clinical assessment of HIV-associated lipodystrophy in an ambulatory population","volume":"15","author":"Lichtenstein","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2012.07.002_bib6","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0140-6736(99)06102-4","article-title":"Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy","volume":"354","author":"Brinkman","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2012.07.002_bib7","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1128\/AAC.00039-07","article-title":"Absence of a universal mechanism of mitochondrial toxicity by nucleoside Analogs","volume":"51","author":"Lund","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2012.07.002_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/135965350400900109","article-title":"Mitochondrial effects of antiretroviral therapies in asymptomatic patients","volume":"9","author":"Lopez","year":"2004","journal-title":"Antivir Ther"},{"issue":"2","key":"10.1016\/j.jinf.2012.07.002_bib9","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1128\/AAC.01122-07","article-title":"Entecavir for treatment of hepatitis B virus displays no in\u00a0vitro mitochondrial toxicity or DNA polymerase gamma inhibition","volume":"52","author":"Mazzucco","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2012.07.002_bib10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/135965350501000112","article-title":"Changes in mitochondrial RNA production in cells treated with nucleoside analogues","volume":"10","author":"Galluzzi","year":"2005","journal-title":"Antivir Ther"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445312001946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445312001946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:17:15Z","timestamp":1759007835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445312001946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0163445312001946"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2012.07.002","relation":{},"ISSN":["0163-4453"],"issn-type":[{"type":"print","value":"0163-4453"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Body fat changes and mitochondrial alterations during HBV treatment: A warning for long term administration","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2012.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}